FDA Approves Eisai And Biogen's Leqembi For Alzheimer's Disease Treatment
7/1 05:31
(RTTNews) - The U.S. Food and Drug Administration approved Eisai Co., Ltd. and Biogen Inc.'s (BIIB) Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer's disease....